Search this site
Embedded Files
Beaumont-Dark Family Office
  • Home
  • Team
  • Case Studies
  • News
  • Contact
Beaumont-Dark Family Office
  • Home
  • Team
  • Case Studies
  • News
  • Contact
  • More
    • Home
    • Team
    • Case Studies
    • News
    • Contact

Micro Cap Alliance 2025 'Top Picks'

I was very pleased to convene the second meeting of our ๐˜œ๐˜’ ๐˜”๐˜ช๐˜ค๐˜ณ๐˜ฐ ๐˜Š๐˜ข๐˜ฑ ๐˜š๐˜ฑ๐˜ฆ๐˜ค๐˜ช๐˜ข๐˜ญ๐˜ช๐˜ด๐˜ต ๐˜๐˜ฏ๐˜ท๐˜ฆ๐˜ด๐˜ต๐˜ฐ๐˜ณ๐˜ด ๐˜Ž๐˜ณ๐˜ฐ๐˜ถ๐˜ฑ recently. In between general market discussion and thoughts on how we can effectively support UK listed smaller companies, this time we each โ€˜pitchedโ€™ two investment ideas for the remainder of 2025, divided into a โ€˜Safeโ€™ and โ€˜Riskyโ€™ category. Below is a list of the names we are watching closely this year, naturally with a bias to small and micro caps!


As you can see, a real spread of sectors, specialisms and sizes, indicating, I think, just how much opportunity we firmly believe there is out there in this much unloved area of the market.


If anyone would like any more information on any of the below, please do get in touch and Iโ€™ll pass on some more detail on the investment case.


As ever, thanks to Miles Nolan, Robert Millington, Graham Bell, David Sheehan, Mark Wharrier, Edward Roskill, William Partridge and others for their insights and contributions!

PS. Highly recommend the Libertine (an Incipio Group property) underneath the Royal Exchange as a venue.

2024 - A Year In Review

Well, what a year itโ€™s been. As I pour myself out (another) glass of something nice, I thought itโ€™s a good opportunity to reflect on the first full year of moving to the buy side and running the ๐˜‰๐˜ฆ๐˜ข๐˜ถ๐˜ฎ๐˜ฐ๐˜ฏ๐˜ต-๐˜‹๐˜ข๐˜ณ๐˜ฌ ๐˜๐˜ข๐˜ฎ๐˜ช๐˜ญ๐˜บ ๐˜–๐˜ง๐˜ง๐˜ช๐˜ค๐˜ฆ. This year has been all about establishing our framework as better investors, formalising processes, challenging our existing holdings, rationalising smaller names in the portfolio, building up relationships and somehow managing time to take a look at some new names. Whilst this certainly doesnโ€™t guarantee alpha, I think it behooves us all as Fund Managers to work on our structures to give us a better ๐˜ค๐˜ฉ๐˜ข๐˜ฏ๐˜ค๐˜ฆ ๐˜ฐ๐˜ง ๐˜ด๐˜ถ๐˜ค๐˜ค๐˜ฆ๐˜ด๐˜ด each time we invest.ย 

Iโ€™m very proud of what weโ€™ve achieved these past twelve months, with a particular highlight being establishing the ๐— ๐—ถ๐—ฐ๐—ฟ๐—ผ ๐—–๐—ฎ๐—ฝ ๐—”๐—น๐—น๐—ถ๐—ฎ๐—ป๐—ฐ๐—ฒ, a network of HNWs, Family Offices and institutions committed to supporting small and micro cap UK listed companies. This included productive meetings with James Ashton of the QCA and Charles Hall of Peel Hunt to discuss how we can continue to promote this often overlooked segment of the market.

Anyway, enough of that wooly stuff, ๐˜ธ๐˜ฉ๐˜ฆ๐˜ณ๐˜ฆ ๐˜ฉ๐˜ข๐˜ท๐˜ฆ ๐˜ธ๐˜ฆ ๐˜ข๐˜ค๐˜ต๐˜ถ๐˜ข๐˜ญ๐˜ญ๐˜บ ๐˜ฅ๐˜ฆ๐˜ฑ๐˜ญ๐˜ฐ๐˜บ๐˜ฆ๐˜ฅ ๐˜ค๐˜ข๐˜ฑ๐˜ช๐˜ต๐˜ข๐˜ญ?

Well, weโ€™ve taken two larger positions, and two opening sizes, as well as numerous trading and arbitrage positions. Our two nursery names are ๐—ข๐—ป๐˜„๐—ฎ๐—ฟ๐—ฑ ๐—ข๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜๐˜‚๐—ป๐—ถ๐˜๐—ถ๐—ฒ๐˜€ and Concurrent, both of whom (although very different) are defined by impressive management, rigorous attention to detail and a real niche which is hard to replicate. We also made a sizeable follow on investment in Gulf Marine Services PLC, whose cashflow characteristics, rapidly improving debt ratios and criminally low valuation has seen this rise to become one of our largest positions. Whilst performance is being somewhat dragged by background warrant / large holder technical selling, in the long term our investment thesis is now more solid than ever, and I see no reason that Mansour Al Alami and Alex Aclimandos, MBA,CMA wonโ€™t continue to drive this impressive business forward. A true example where, having carried out extensive due diligence and meetings, we stick to our confidence in the company, rather than being influenced by market noise. Finally, our largest new position is in ๐—ข๐—ป๐—ฑ๐—ถ๐—ป๐—ฒ ๐—•๐—ถ๐—ผ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น, where we played a reasonable part in the 8.5p placing during November. Whilst we are by no means biotech / healthcare investors (this being our only major holding in the sector), we met with Carolyn Cross and couldnโ€™t have been more impressed. Best in class technology in an incredibly important area (preventing costly and life threatening infections which are contracted in healthcare settings), along with support from leading industry players - such as Molnlycke and HCA, who are operating the trial - all added up in our mind to a high risk, but hopefully very high reward and socially impactful investment.

We closed or nearly closed (painfully) our equity stakes in ECO BUILDINGS (where we had built up our position when it was the old Fox Marble) as well as Revolution Bars Group PLC (now, weirdly, The Revel Collective). The latter, curiously, we were not brought inside on the 1p raise by house broker, Cavendish, despite being a 3.74% shareholder and having taken part in both 20p raises previously. A little odd! Both these exits were majorly in the red, which is never a great sight, but Iโ€™m confident we learned a lot from these mistakes.

Arb names we were involved with included Kin & Carta, Learning Technologies, Impellam, National World, Keyword Studios, Eckoh, STM, Trinity E&P, as well as riding the Equals and Benchmark sagas through the year. Mostly a success, but, as with all arbs, not without risk!

๐˜ˆ๐˜ด๐˜ช๐˜ฅ๐˜ฆ ๐˜ง๐˜ณ๐˜ฐ๐˜ฎ ๐˜ต๐˜ฉ๐˜ฆ ๐˜ธ๐˜ช๐˜ฅ๐˜ฆ๐˜ณ ๐˜‰๐˜‹๐˜๐˜– ๐˜ฑ๐˜ช๐˜ฆ๐˜ค๐˜ฆ, ๐˜ธ๐˜ฉ๐˜ข๐˜ต ๐˜ฅ๐˜ช๐˜ฅ ๐˜, ๐˜ฑ๐˜ฆ๐˜ณ๐˜ด๐˜ฐ๐˜ฏ๐˜ข๐˜ญ๐˜ญ๐˜บ, ๐˜ญ๐˜ฆ๐˜ข๐˜ณ๐˜ฏ?

Well, firstly, that this is a very strange and unique job. 99% of the work we do - to analyse a company, prepare for meeting management, reading report and accounts - ultimately comes to โ€˜nothingโ€™ when we donโ€™t invest. Additionally, given we generally operate on a minimum of a five year horizon, it is fundamentally too early to measure any kind of success. And, by the time those years roll by, itโ€™ll be too late often to do anything about it! All we can do is stay courageous, keep intellectually open, challenge our assumptions, learn from everyone around us, ask questions and make constant tiny improvements.

Most importantly, a ๐—ต๐˜‚๐—ด๐—ฒ ๐˜๐—ต๐—ฎ๐—ป๐—ธ ๐˜†๐—ผ๐˜‚ to everyone who has supported us, worked with us and put up with my insane level of questioning during meetings. To all the people who have passed on tips, shared their wisdom, told me Iโ€™m doing something completely wrong or simply provided somewhere to bounce ideas off, thank you. I couldnโ€™t do what I do without the huge network of support that often goes overlooked.

Iโ€™m proud of what we have achieved this year, a thoroughly enjoyable laying of the foundations, so hereโ€™s to 2025 - the year the UK equity bounces back?

UK Micro Cap Specialist Investors Lunch

Iโ€™ve always believed that investing, particularly in small and micro cap companies, is first and foremost about people. People to listen to, people to debate ideas with and, most importantly, people to learn from.


Thatโ€™s why it was such a privilege to host the inaugural UK Micro Cap Specialist Investors lunch, bringing together a group of highly experienced and knowledgeable fellow professionals focused on this often overlooked area of the market.


There are plenty of gems and success stories to be found in the UK sub c.ยฃ100m segment- so much so that in over four hours of discussion we barely even scratched the surface. We shared ideas, top picks, chatted through our favourite companies, ones to watch, and offered wider market thoughts and sentiments.


As portfolio managers particularly focused in this sector, the Beaumont-Dark Family Office is proud to support smaller growth companies, and we continue to believe this market segment will offer superior returns.


To (misquote) Mark Twain, the reports of UK micro capโ€™s death have been greatly exaggerated!


I look forward to our next meeting soonโ€ฆ


Report abuse
Page details
Page updated
Report abuse